Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 600
Avg Vol 29,404
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 53%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, a biofilm destabilizing formula with continuous activity; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine (PNAG) for treating wounds and otic...

Industry: Biotechnology
Sector: Healthcare
Phone: 204-453-1301
Address:
290-100 Innovation Drive, Winnipeg, Canada
Latest News on KNBIF
No data available.